Noven Pharmaceuticals, Inc. - Strategy and SWOT Report
is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Detailed information on Noven Pharmaceuticals, Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Noven Pharmaceuticals, Inc. in the form of a SWOT analysis
An in-depth view of the business model of Noven Pharmaceuticals, Inc. including a breakdown and examination of key business segments
Intelligence on Noven Pharmaceuticals, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Noven Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Noven Pharmaceuticals (Noven or 'the company'), a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., is a specialty pharmaceutical company engaged in the research, development, manufacture, marketing and sale of prescription pharmaceutical products in the areas of women's health and central nervous system. The company, through its strategic alliances, operates in the US, Europe and Japan. It is headquartered in Miami, Florida, and employs more than 700 people. Noven has not released its financial results. Therefore, the company's financial data including total revenues and operating and net profits are not available.
Reasons to Purchase:
Gain understanding of Noven Pharmaceuticals, Inc. and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Noven Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Noven Pharmaceuticals, Inc.’s business structure, strategy and prospects